Skip to main content
. 2023 Feb 3;14:1117076. doi: 10.3389/fendo.2023.1117076

Table 4.

Gene expression markers linked to T1D progression.

Authors Year Type of participants Sample type miRNA and mRNA genes
Santos et al., ( 37 ) 2022 IAb+ vs. ROT1D vs. health control Serum 17 miRNAs were deregulated in IAb+ and 5 in ROT1D compared to healthy controls
Garavelli et al., ( 16 ) 2020 ROT1D vs. healthy controls Plasma 27 of 60 miRNAs were modulated including 18 of 27 from the miR-23~27~24 clusters
Simmons et al., ( 31 ) 2019 ROT1D vs. IAb+ Serum
DNA
↑unmethylated:methylated INS ratio
Mehdi et al., ( 10 ) 2018 Progressors to IAb+ vs. IAb- Whole blood (DIPP), PBMC (BABYDIET) Predictors of seroconversion ADCY9, PTCH1, MEX3B, ZNF714, TENM1, PLEKHA5 with HLA risk score
Snowhite et al., ( 32 ) 2017 IAb+ Progressors to T1D vs. non-progressors Serum miR-21-3p, ↑miR-29a-3p, ↑miR-424-5p
Hamari et al., ( 18 ) 2016 IAb+ vs. ROT1D Whole blood T-bet, ↓GATA3, ↓ RORC, ↓FOXP3
Marchand et al., ( 24 ) 2016 ROT1D vs IAb- Serum miR-375
Jin et al., ( 22 ) 2014 IAb+ Progressors to T1D vs. non-progressors Whole blood BACH2, ↑IGLL3, ↑ EIF3A, ↑CDC20,
TXNDC5
Ferreira et al., ( 15 ) 2014 IAb+ (before and after seroconversion) vs. IAb- PBMC ↑type-1 IFN gene signature (includes 56 IFN-inducible genes)
Nielsen et al., ( 25 ) 2012 ROT1D vs. IAb+ Serum miR-181a, ↑miR-24, ↑miR-25, ↑miR-210, ↑miR-26a, ↑miR-152, ↑miR-30a-5p, ↑miR-148a, ↑miR-200a, ↑miR-29a, ↑miR-27b, ↑miR-27a
Han et al., ( 19 ) 2011 ROT1D and IAb+ vs. healthy controls Whole blood IFN-γ, ↑IL-4, ↑IL-10 in ROT1D vs IAb+
↓granzyme B, ↓TNFα, ↓IFN-γ in IAb+ vs healthy controls

ADCY9, Adenylate cyclase type 9; GATA3, GATA binding protein 3; IAb, islet autoantibody; MEX38, Mex-3 RNA Binding Family Member B; miRNA, MicroRNA; PLEKHA5, Pleckstrin Homology Domain Containing A5; PTCH1, Protein patched homolog 1; ROT1D, recent-onset type 1 diabetes; TENM1, Teneurin Transmembrane Protein 1; TENM1, Teneurin Transmembrane Protein 1; ZNF714, Zinc finger 714.